中文导读

晚期视网膜色素变性患者可能几乎完全失明。一项发表于《新英格兰医学杂志》的小型试验，用一次基因注射加上特制光刺激护目镜，帮助部分参与者提高光敏感度，并完成探测、定位物体等任务。本文说明方法原理、主要结果与仍存局限。据ScienceAlert 2026年10月14日报道及UPMC、GenSight等公开说明撰写。

正文

For people with a severe eye disease called retinitis pigmentosa, light detection often fades over years. Night vision usually goes first, then the edges of sight, and some patients become profoundly blind. An experimental treatment now reported in The New England Journal of Medicine has helped some of them regain limited abilities. The approach combines one gene injection with special light-stimulating goggles. ScienceAlert covered the study on October 14, 2026.

本段译文

对患有严重眼病视网膜色素变性的人来说，光感知往往会在多年间逐渐减弱。夜视通常最先变差，随后是视野边缘，有些人最终几乎完全失明。《新英格兰医学杂志》新近报告的一项试验性治疗，已帮助部分患者恢复有限能力。该方法把一次基因注射与特制光刺激护目镜结合起来。ScienceAlert于2026年10月14日报道了这项研究。

The trial enrolled 10 adults who had lost almost all useful vision in both eyes. Each person received a single injection in the worse-seeing eye. A modified virus carried instructions for a light-sensitive protein called ChrimsonR into retinal ganglion cells. Those nerve cells normally pass visual signals toward the brain, but they do not sense light themselves. After the gene therapy, they could respond to amber light.

本段译文

试验招募了10名双眼几乎失去可用视力的成年人。每人在视力较差的那只眼接受单次注射。一种经过改造的病毒把制造光敏感蛋白ChrimsonR的指令送入视网膜神经节细胞。这些神经细胞通常负责向大脑传递视觉信号，本身并不感光。基因治疗后，它们能够对琥珀色光作出反应。

The goggles were essential. A camera captured changes in brightness. A processor turned those changes into patterns of amber light, and a projector sent the patterns onto the treated retina. Researchers tested light sensitivity with the untreated eye covered. Seven of the 10 participants became more sensitive, with gains from about twofold to 62-fold. Six reached roughly a fourfold increase or more, a level the team viewed as clinically meaningful.

本段译文

护目镜必不可少。摄像头捕捉亮度变化，处理器把这些变化转成琥珀色光图案，再由投影仪投到经过治疗的视网膜上。研究者在遮盖未治疗眼的情况下测试光敏感度。10名参与者中有7人变得更敏感，增幅约从2倍到62倍。6人达到约4倍或以上，研究团队认为这一水平具有临床意义。

Object tests told a more mixed story. Eight people completed tasks such as finding a notebook, locating a small box, or judging the orientation of a bar, both with and without the goggles. Four consistently did better at detecting the notebook across sessions lasting about a year to a year and a half. Others showed no stable gain. Differences may reflect how well the therapy reached remaining cells, or how much practice each person had with the device.

本段译文

物体测试结果更为复杂。8人完成了寻找笔记本、定位小盒子或判断木条方向等任务，并分别在戴与不戴护目镜时比较。4人在约一年到一年半的多次会话中，探测笔记本的表现持续更好；其他人没有稳定提升。差异可能反映治疗到达残余细胞的效果，或各人对设备的训练量。

Safety was the primary goal. The authors recorded 34 eye-related events among nine participants, mostly mild or moderate. Seven developed inflammation inside the eye that resolved with treatment. One severe event was a brief blockage of a retinal artery right after injection; it cleared within minutes after medication. Within this small group, the team judged safety acceptable, while noting that larger studies are still needed.

本段译文

安全性是主要目标。作者在9名参与者中记录了34起眼部相关事件，多为轻中度。7人出现眼内炎症，经治疗后消退。一起严重事件是注射后视网膜动脉短暂阻塞，用药后数分钟内解除。在这个小组范围内，团队认为安全性可接受，同时指出仍需更大规模研究。

The method is called optogenetic therapy. Instead of repairing every damaged light-detecting cell, it gives surviving nerve cells a new way to respond to light. Patients did not regain reading or face recognition. Sahel, Roska and colleagues say greater sensor sensitivity remains a goal. For now, the results show that gene therapy plus adaptive goggles can restore fragments of useful vision in carefully selected people with late-stage disease.

本段译文

这种方法称为光遗传学治疗。它并不修复每一个受损的感光细胞，而是给存活的神经细胞一种新的感光方式。患者并未恢复阅读或辨认面孔的能力。Sahel、Roska及同事表示，提高传感器敏感度仍是目标。目前结果表明，在经过仔细筛选的晚期患者中，基因治疗加上自适应护目镜可以恢复片段式的可用视觉。

新闻来源

• ScienceAlert · Partial Vision Restored in Some Blind Patients With New Experimental Treatment (14 Oct 2026)
• UPMC · Optogenetic Therapy Shows Signs of Vision Restoration
• GenSight Biologics · NEJM Publication on GS030 PIONEER Trial (8 Oct 2026)

✳更多文章 →